300PLong-term responders to trastuzumab monotherapy in the first-line metastatic setting: characteristics and survival data (SAKK 22/99 Trial)
Schmid, S., Klingbiel, D., Goldhirsch, A., Oehlschlegel, C., Munzone, E., Nolè, F., Pestalozzi, B., Aebi, S., Rochlitz, C., von Moos, R., Zaman, K., Mamot, C., Weder, P., Thuerlimann, B., Pagani, O.,Volume:
28
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx365.063
Date:
September, 2017
File:
PDF, 92 KB
2017
File converter
More search results
More benefits 
